<DOC>
	<DOCNO>NCT01340131</DOCNO>
	<brief_summary>The purpose study evaluate pharmacokinetic characteristic CKD-828 ( Fixed Dose Combination Tablet ; Telmisartan S-Amlodipine ) healthy volunteer .</brief_summary>
	<brief_title>CKD-828 ( 40/5mg ) Pharmacokinetic Study</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Telmisartan</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>A healthy volunteer 20 55 year old body weight within 20 % ideal body weight . Have congenital chronic disease medical symptom . Appropriate study judge examination ( interview , vital sign , 12lead ECG , physical examination , blood , urinalysis result screen ) . Able participate entire trial . Signed informed consent form prior study participation . Take metabolic enzyme induce inhibit drug like barbiturate within 28 day prior first IP administraion . The evidence acute disease within 28 day prior first IP administraion . Disease ( ex : imflammatory intestinal disease , gastric duodenal ulcer , hepatic diseasehistory , gastro intestinal surgery exept appendectomy ) may influence absorption , distribution , metabolism excretion drug ( ) . Relevant hypersensitivity drug clinically significant allergic disease except mild rhinitis n't need medication . Hypersensitivity Telmisartan Amlodipine . SBP &lt; 90mmHg DBP &lt; 50mmHg . Abnormal laboratory result ( ) : AST ALT &gt; 1.25 time upper limit / Total bilirubin &gt; 1.5 time upper limit . A drug abuse heavy caffeine consumer ( 5 cup per day ) heavy smoker ( 10 cigarette per day ) regular alcohol consumer ( 30g/day ) drinking within 7days prior first IP administration . Diet ( Especially , grapefruit juicewithin 7 day prior first IP administraion ) may influence absorption , distribution , metabolism excretion drug ( ) . Donated whole blood within 60 day prior first IP administraion . Participated clinical trial within 90days prior first IP administraion . Medicine within 10 day prior first IP administraion ? Does medication affect trial . Appropriate trial judging principal investigator .</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>CKD-828</keyword>
	<keyword>Hypertension</keyword>
	<keyword>Primary Hypertension</keyword>
	<keyword>Healthy Volunteer</keyword>
	<keyword>S-Amlodipine</keyword>
	<keyword>Telmisartan</keyword>
	<keyword>Amlodipine</keyword>
	<keyword>Pharmacokinetic</keyword>
	<keyword>Phase 1</keyword>
</DOC>